Cite
Neoadjuvant therapy bridging patients with hepatocellular cancer waiting for liver transplant
MLA
A. A. Pitkevich, et al. “Neoadjuvant Therapy Bridging Patients with Hepatocellular Cancer Waiting for Liver Transplant.” Meditsinskiy Sovet = Medical Council, Dec. 2021, pp. 110–16. EBSCOhost, https://doi.org/10.21518/2079-701x-2021-20-110-116.
APA
A. A. Pitkevich, V. Yu. Kosyrev, I. A. Dzhanyan, M. S. Novruzbekov, A. R. Monakhov, S. I. Zubenko, S. E. Voskanyan, V. S. Rudakov, E. A. Moroz, & V. V. Breder. (2021). Neoadjuvant therapy bridging patients with hepatocellular cancer waiting for liver transplant. Meditsinskiy Sovet = Medical Council, 110–116. https://doi.org/10.21518/2079-701x-2021-20-110-116
Chicago
A. A. Pitkevich, V. Yu. Kosyrev, I. A. Dzhanyan, M. S. Novruzbekov, A. R. Monakhov, S. I. Zubenko, S. E. Voskanyan, V. S. Rudakov, E. A. Moroz, and V. V. Breder. 2021. “Neoadjuvant Therapy Bridging Patients with Hepatocellular Cancer Waiting for Liver Transplant.” Meditsinskiy Sovet = Medical Council, December, 110–16. doi:10.21518/2079-701x-2021-20-110-116.